uniQure
QURE
#5548
Rank
โ‚น112.75 B
Marketcap
โ‚น1,810
Share price
-3.08%
Change (1 day)
39.39%
Change (1 year)

uniQure (QURE) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น62.39 Billion

According to uniQure's latest financial reports the company has โ‚น62.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

uniQure - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น31.52 B-38.71%
2023-12-31โ‚น51.43 B76.17%
2022-12-31โ‚น29.19 B-29.48%
2021-12-31โ‚น41.40 B131.13%
2020-12-31โ‚น17.91 B-33.51%
2019-12-31โ‚น26.94 B64.03%
2018-12-31โ‚น16.42 B61.41%
2017-12-31โ‚น10.17 B13.02%
2016-12-31โ‚น9.00 B-38.87%
2015-12-31โ‚น14.72 B259.09%
2014-12-31โ‚น4.10 B101.92%
2013-12-31โ‚น2.03 B10565.94%
2012-12-31โ‚น19.04 M-74.75%
2011-12-31โ‚น75.41 M-92.91%
2010-12-31โ‚น1.06 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
โ‚น848.89 B 1,260.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น2.66 B-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚น7.07 B-88.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚น168.59 B 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น939.39 B 1,405.51%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
โ‚น132.82 B 112.87%๐Ÿ‡บ๐Ÿ‡ธ USA